X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (155921) 155921
Newsletter (37858) 37858
Newspaper Article (22481) 22481
Publication (15329) 15329
Book Review (1283) 1283
Book Chapter (1102) 1102
Magazine Article (822) 822
Trade Publication Article (779) 779
Web Resource (503) 503
Dissertation (352) 352
Conference Proceeding (237) 237
Transcript (225) 225
Book / eBook (222) 222
Report (140) 140
Government Document (46) 46
Reference (45) 45
Data Set (33) 33
Journal / eJournal (25) 25
Paper (18) 18
Streaming Video (10) 10
Poster (4) 4
Presentation (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (100775) 100775
hepatitis (59912) 59912
index medicus (58249) 58249
male (53165) 53165
female (52530) 52530
hepatitis c virus (51582) 51582
adult (42230) 42230
hepatitis c (40400) 40400
middle aged (38781) 38781
health aspects (36124) 36124
infection (31693) 31693
research (30674) 30674
gastroenterology & hepatology (28082) 28082
hepatitis b (26976) 26976
infections (21008) 21008
virology (20745) 20745
medical research (20637) 20637
interferon (20286) 20286
liver (19852) 19852
aged (19700) 19700
infectious diseases (19563) 19563
risk factors (18837) 18837
hepatitis b virus (18780) 18780
animals (17729) 17729
medicine, experimental (17637) 17637
viruses (17511) 17511
virus diseases (16268) 16268
immunology (15975) 15975
analysis (15830) 15830
prevalence (15625) 15625
antiviral agents - therapeutic use (14095) 14095
liver diseases (13971) 13971
care and treatment (13968) 13968
adolescent (13783) 13783
hiv (13539) 13539
antiviral agents (12504) 12504
genotype (11851) 11851
hepacivirus - genetics (11337) 11337
epidemiology (10426) 10426
liver cancer (10377) 10377
virus-infection (10342) 10342
liver cirrhosis (10020) 10020
genetic aspects (9896) 9896
treatment outcome (9761) 9761
disease (9591) 9591
communicable diseases (9349) 9349
microbiology (9108) 9108
hepatitis-c virus (9085) 9085
human immunodeficiency virus--hiv (9047) 9047
therapy (8917) 8917
drug therapy (8865) 8865
cirrhosis (8863) 8863
hepatitis c, chronic - drug therapy (8678) 8678
hepatocellular-carcinoma (8639) 8639
biological response modifiers (8485) 8485
young adult (8442) 8442
cancer (8426) 8426
hepatocellular carcinoma (8415) 8415
patients (8375) 8375
rna (8340) 8340
medicine, general & internal (8280) 8280
medicine (7964) 7964
transplantation (7921) 7921
child (7819) 7819
hepatitis c - epidemiology (7803) 7803
hcv (7727) 7727
hepatitis b virus - genetics (7706) 7706
retrospective studies (7609) 7609
proteins (7580) 7580
ribavirin (7510) 7510
digestive system diseases (7494) 7494
hepatitis c - complications (7433) 7433
mice (7352) 7352
research article (7261) 7261
vaccines (7071) 7071
diagnosis (7059) 7059
risk (6945) 6945
antibodies (6874) 6874
universities and colleges (6853) 6853
oncology (6846) 6846
mortality (6670) 6670
vaccination (6670) 6670
antigens (6637) 6637
gastroenterology and hepatology (6557) 6557
polymerase chain reaction (6514) 6514
pharmaceutical industry (6494) 6494
studies (6491) 6491
virus (6386) 6386
prevention (6378) 6378
interferon-alpha - therapeutic use (6335) 6335
public health (6253) 6253
pharmacology & pharmacy (6221) 6221
hepatology (6129) 6129
liver - pathology (6048) 6048
expression (6010) 6010
drug therapy, combination (6004) 6004
surgery (5931) 5931
viral load (5917) 5917
molecular sequence data (5813) 5813
fibrosis (5794) 5794
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (100) 100
Online Resources - Online (53) 53
Collection Dvlpm't (Acquisitions) - Vendor file (12) 12
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Robarts - Government Pubs (2) 2
Scarborough Hospital - Online (2) 2
St. Michael's Hospital - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (212376) 212376
French (1996) 1996
Spanish (1457) 1457
German (928) 928
Japanese (614) 614
Korean (569) 569
Chinese (522) 522
Russian (388) 388
Portuguese (234) 234
Turkish (227) 227
Polish (176) 176
Italian (168) 168
Hungarian (126) 126
Czech (59) 59
Croatian (53) 53
Serbian (36) 36
Dutch (34) 34
Persian (28) 28
Romanian (27) 27
Arabic (18) 18
Danish (17) 17
Hebrew (14) 14
Slovenian (11) 11
Urdu (11) 11
Norwegian (10) 10
Swedish (10) 10
Bosnian (7) 7
Lithuanian (5) 5
Ukrainian (5) 5
Catalan (4) 4
Bulgarian (3) 3
Icelandic (3) 3
Slovak (3) 3
Albanian (1) 1
Finnish (1) 1
Hindi (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 25, pp. 2405 - 2416
In patients with HCV infection and no previous treatment, the addition of telaprevir to peginterferon–ribavirin resulted in higher response rates than those... 
GENETIC-VARIATION | IL28B | MEDICINE, GENERAL & INTERNAL | HEPATOCELLULAR-CARCINOMA | GENOTYPE-1 PATIENTS | PEGINTERFERON ALPHA-2B | AMERICAN PATIENTS | ALPHA-2B PLUS RIBAVIRIN | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Recombinant Proteins | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Viral Load | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Young Adult | Serine Proteinase Inhibitors - adverse effects | Adult | Female | Drug Therapy, Combination | Hepacivirus - isolation & purification | Double-Blind Method | Antiviral Agents - therapeutic use | Interferon-alpha - therapeutic use | Logistic Models | Hepatitis C, Chronic - drug therapy | Sequence Analysis, DNA | Antiviral Agents - adverse effects | Aged | Interferon-alpha - adverse effects | Peginterferon alfa-2b | Patient outcomes | Genetic aspects | Hepatitis C | Drug therapy | Comparative analysis | Health aspects | Fees & charges | Antiretroviral drugs | Liver diseases | Clinical trials | Chronic infection | Employees | Infections | Proteinase inhibitors | Genomes | Ribonucleic acid--RNA | Patients | Ribavirin | Liver cancer | Genotype & phenotype | Hepatitis | Skin | Interferon | Genotypes | Pharmaceuticals
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 11/2016, Volume 165, Issue 9, pp. 625 - 634
Journal Article
Journal Article